[go: up one dir, main page]

ZA200901364B - Method of treatment of photodermatoses - Google Patents

Method of treatment of photodermatoses

Info

Publication number
ZA200901364B
ZA200901364B ZA200901364A ZA200901364A ZA200901364B ZA 200901364 B ZA200901364 B ZA 200901364B ZA 200901364 A ZA200901364 A ZA 200901364A ZA 200901364 A ZA200901364 A ZA 200901364A ZA 200901364 B ZA200901364 B ZA 200901364B
Authority
ZA
South Africa
Prior art keywords
photodermatoses
treatment
Prior art date
Application number
ZA200901364A
Other languages
English (en)
Inventor
Philippe Wolgen
Original Assignee
Clinuvel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006904745A external-priority patent/AU2006904745A0/en
Application filed by Clinuvel Pharmaceuticals Ltd filed Critical Clinuvel Pharmaceuticals Ltd
Publication of ZA200901364B publication Critical patent/ZA200901364B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200901364A 2006-08-31 2007-08-31 Method of treatment of photodermatoses ZA200901364B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006904745A AU2006904745A0 (en) 2006-08-31 Method for Treatment of Photodermatoses
AU2007900862A AU2007900862A0 (en) 2007-02-21 Method for treatment of photodermatoses

Publications (1)

Publication Number Publication Date
ZA200901364B true ZA200901364B (en) 2010-06-30

Family

ID=39135428

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901364A ZA200901364B (en) 2006-08-31 2007-08-31 Method of treatment of photodermatoses

Country Status (17)

Country Link
US (1) US8334265B2 (xx)
EP (2) EP2056855B1 (xx)
AU (1) AU2007291886B2 (xx)
CA (1) CA2662163C (xx)
CY (1) CY1115804T1 (xx)
DK (2) DK2056855T3 (xx)
ES (2) ES2646049T3 (xx)
HK (1) HK1130208A1 (xx)
HU (2) HUE035074T2 (xx)
LU (1) LUC00062I2 (xx)
NL (1) NL300926I2 (xx)
NZ (1) NZ575133A (xx)
PL (2) PL2056855T3 (xx)
PT (2) PT2056855E (xx)
SI (2) SI2056855T1 (xx)
WO (1) WO2008025094A1 (xx)
ZA (1) ZA200901364B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200901365B (en) * 2006-08-28 2010-05-26 Clinuvel Pharmaceuticals Ltd Method for reducing incidence or rate of development of skin cancers and related conditions
WO2009103816A1 (en) * 2008-02-22 2009-08-27 Clinuvel Pharmaceuticals Limited Method for treatment of photosensitivity and phototoxicity
SI2957292T1 (en) * 2008-03-27 2018-04-30 Clinuvel Pharmaceuticals Limited Vitiligo therapy
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
EP2487185A1 (en) * 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
US9371555B2 (en) 2012-06-01 2016-06-21 Concordia Laboratories Inc. Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin
EP3008184A1 (en) * 2013-06-13 2016-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the treatment of erythropoietic protoporphyria
WO2015063099A1 (en) * 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en) * 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in bullous disease
EP3088417A1 (en) 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
EP3088418A1 (en) 2015-04-28 2016-11-02 Vallaurix Pte. Ltd. Pharmaceutical compound
WO2018142318A1 (en) * 2017-02-01 2018-08-09 Clinuvel Pharmaceuticals Ltd Alpha-msh analogues used in the treatment of xeroderma pigmentosum
AR122595A1 (es) 2020-06-10 2022-09-21 Mitsubishi Tanabe Pharma Corp Agente profiláctico o terapéutico para fotodermatosis
EP4166140A4 (en) 2020-06-10 2024-07-10 Mitsubishi Tanabe Pharma Corporation Prophylactic or therapeutic agent for porphyria
WO2021251450A1 (ja) 2020-06-10 2021-12-16 田辺三菱製薬株式会社 ポルフィリン症の予防又は治療剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457864A (en) 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin
WO1987004623A1 (en) * 1986-02-03 1987-08-13 University Patents, Inc. Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same
US5674839A (en) 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5049547A (en) 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
JP2002512501A (ja) 1996-07-03 2002-04-23 メリアル インコーポレイテッド 外来性ｄｎａを含む組換えイヌアデノウィルス（ｃａｖ）
US5990091A (en) 1997-03-12 1999-11-23 Virogenetics Corporation Vectors having enhanced expression, and methods of making and uses thereof
WO1999060164A1 (en) 1998-05-15 1999-11-25 Quark Biotech, Inc. Mechanical stress induced genes, expression products therefrom, and uses thereof
CA2475985A1 (en) * 2002-02-26 2003-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method of stimulation of melanin production and induction of skin tanning
DK1789076T3 (en) 2004-08-04 2016-04-11 Clinuvel Pharmaceuticals Ltd METHODS for inducing melanogenesis in a subject
EP2939686A1 (en) * 2004-10-08 2015-11-04 Clinuvel Pharmaceuticals Limited Compositions and methods for inducing melanogenesis in a subject
ZA200901365B (en) * 2006-08-28 2010-05-26 Clinuvel Pharmaceuticals Ltd Method for reducing incidence or rate of development of skin cancers and related conditions

Also Published As

Publication number Publication date
NL300926I2 (nl) 2018-03-20
ES2646049T3 (es) 2017-12-11
US20100120668A1 (en) 2010-05-13
SI2056855T1 (sl) 2015-01-30
PL2056855T3 (pl) 2015-04-30
CA2662163A1 (en) 2008-03-06
WO2008025094A1 (en) 2008-03-06
HUS1800006I1 (hu) 2018-05-02
CA2662163C (en) 2015-11-24
EP2865422A1 (en) 2015-04-29
NZ575133A (en) 2011-11-25
CY1115804T1 (el) 2017-01-25
LUC00062I2 (xx) 2018-03-28
ES2525476T3 (es) 2014-12-23
EP2056855B1 (en) 2014-09-17
AU2007291886A1 (en) 2008-03-06
EP2865422B1 (en) 2017-10-18
HUE035074T2 (en) 2018-05-02
US8334265B2 (en) 2012-12-18
LUC00062I1 (xx) 2018-02-08
EP2056855A4 (en) 2013-06-19
PL2865422T3 (pl) 2018-01-31
PT2056855E (pt) 2014-12-12
SI2865422T1 (sl) 2017-12-29
HK1130208A1 (en) 2009-12-24
AU2007291886B2 (en) 2013-01-10
EP2056855A1 (en) 2009-05-13
DK2056855T3 (en) 2014-12-15
PT2865422T (pt) 2017-11-14
DK2865422T3 (da) 2017-11-20

Similar Documents

Publication Publication Date Title
ZA200901364B (en) Method of treatment of photodermatoses
EP2032131A4 (en) Methods of Treatment
GB0610746D0 (en) Method of treatment
IL193460A0 (en) Compounds and methods for treatment of stroke
EP2174912A4 (en) PROCESS FOR MACHINING A COPPER ARSEN COMPOUND
ZA200806349B (en) Method for treatment of neuropathic pain
EP2034830A4 (en) PROCESS FOR TREATMENT OF STROKE
EP2350641A4 (en) Methods of Treatment
GB0608190D0 (en) Method of purification
ZA200907349B (en) Method of treating hair
VN25747A1 (en) Method of water treatment
EP2144886A4 (en) METHOD OF TREATING MELANOMA
GB0718684D0 (en) Treatment method
IL202002A0 (en) Method of treating diabetes
EP2194793A4 (en) PROCESS FOR TREATING FRESH FRUITS AND VEGETABLES
EP2164494A4 (en) Methods of Treatment
EP2011767A4 (en) WATER TREATMENT PROCESS
EP2094385A4 (en) METHOD OF WASTE WATER TREATMENT
EP2203432A4 (en) PROCESSING METHOD
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0618227D0 (en) Novel method of treatment
AU2006904745A0 (en) Method for Treatment of Photodermatoses
GB0717337D0 (en) Method of treatment
AU2007900862A0 (en) Method for treatment of photodermatoses
GB0522330D0 (en) Method of treatment